A multicenter, retrospective study analyzing clinical efficacy of biologic agents available in France for severe asthma
Latest Information Update: 09 Mar 2023
At a glance
- Drugs Benralizumab (Primary) ; Dupilumab (Primary) ; Mepolizumab (Primary) ; Omalizumab (Primary)
- Indications Asthma; Nasal polyps; Rhinosinusitis
- Focus Therapeutic Use
Most Recent Events
- 09 Mar 2023 New trial record